Medical Device Media Reporting Pioneer
Share Professional Medical Device Knowledge
Source:Instrument Family,Reproduction without authorization is prohibited, and reproduction is allowed 24 hours later.
United States, March 18Johnson & Johnson Medical Technology announced a cooperation agreement with NVIDIA, and the two parties will jointly develop new artificial intelligence applications.
According to the agreement,Johnson & Johnson to Gain Access to NVIDIA’s IGX Edge Computing Platform and Holoscan Edge AI Platform. Aiming to leverage NVIDIA’s computing platforms and artificial intelligence technologies to support real-time data analysis for surgical software and devices in operating rooms, thereby advancing the level of surgical performance.At the same time,The two parties also plan to apply AI technology in the fields of medical image analysis and disease diagnosis.This will provide doctors with more comprehensive medical information, helping them make accurate diagnoses and treatment decisions more quickly.In addition,The collaboration will also involve the field of medical education and training.By leveraging NVIDIA's virtual reality and augmented reality technologies, medical students and doctors can undergo more realistic and effective training, enhancing their skill levels and professional competence.Shan Jegatheeswaran, Global Digital Head of Johnson & Johnson Medical Technologies, stated: "One of the main challenges in expanding artificial intelligence in surgery is the closed nature of surgical techniques."Introducing advanced edge computing hardware and software into operating rooms enables innovative scalability and new AI-driven solutions for clinical decision-making, education and training, and collaboration, with the ultimate goal of advancing patient care.”
Medical EdgeEdge AI NVIDIA IGXIt is reported that,NVIDIA IGX is an advanced hardware and software solution designed by NVIDIA for edge computing applications, integrating NVIDIA's latest AI technologies, including deep learning algorithms and neural network models, enabling devices with intelligent capabilities.Aimed at providing powerful artificial intelligence (AI) capabilities and real-time data processing abilities for various fields, including the medical field.For edge AI use cases in the healthcare industry, IGX provides secure, low-latency AI inference to meet the clinical need for immediate insights from a range of instruments and sensors during medical procedures, such as robotic-assisted surgery and patient monitoring systems.
In addition,The IGX platform can support NVIDIA Clara Holoscan, a real-time AI computing platform for medical devices.Empower medical device developers to integrate edge, local data centers, and cloud services, enabling rapid development and deployment of new devices, delivering AI applications directly into operating rooms where over 300 million surgeries are performed globally each year.The Holoscan platform combines hardware systems for low-latency sensors and network connectivity, optimized libraries for data processing and artificial intelligence, and core microservices for running streaming, imaging, and other applications.From embedded to edge to cloud.It can make real-time data processing a reality through high-throughput data transmission and processing. For example, real-time analysis of pathological data. The data volume of pathological images is extremely large, even up to several TB. It is basically impossible to perform real-time analysis on pathological data.With the Clara Holoscan platform, researchers have reduced the analysis time of cancer cell pathology images from 2 days to real-time, and for the first time, observed in real-time a single cancer cell dividing into three cancer cells.Update 25 Medical Microservices
Notably, on the same day that NVIDIA signed a cooperation agreement with Johnson & Johnson, it also launched a new AI inference server—NVIDIA NIM—a new software platform designed to simplify the deployment of customized and pre-trained AI models in production environments.Through NIM, users can experience various AI models and applications while retaining full control over intellectual property.Companies in the medical industry can base these microservices,Screening trillions of drug compounds, collecting more patient data to aid in early disease detection, or implementing smarter digital assistants.Etc.
Johnson & Johnson Advances in Artificial IntelligenceAs the world's largest and most diversified healthcare enterprise, Johnson & Johnson had long maintained its position as the global leader in the medical device industry, but was later surpassed by Medtronic. In recent years, the company has been increasingly focusing on the surgical robotics field, striving to transform itself into a giant in surgical robotics.During Johnson & Johnson's earnings call in January, Chief Financial Officer Joe Wolk stated,The company is currently seeking opportunities, whether through artificial intelligence or overall infrastructure, to further improve the profitability of medical technology.
The primary goal of this collaboration is alsoIntegrating these two NVIDIA platforms into Johnson & Johnson’s surgical technology product portfolio,To build better and smarter AI products for their offerings. Currently, Johnson & Johnson Medical Technologies' surgical robot products includeMonarch Natural Orifice Diagnostic and Therapeutic Robot, VELYS Orthopedic Surgical Robot, etc.Monarch Natural Orifice Diagnostic and Therapeutic Robot
Monarch is the first diagnosis and treatment robot approved in China that operates through natural orifices., applicable to diagnosis and treatment via bronchoscopy.AsIs the world's leading digital surgery platform. Monarch has appliedThe world's first endoscopic technology with "three-in-one" navigation: full-process visualization, electromagnetic navigation, and virtual reconstruction., After the endoscope enters the human body, it can provide continuous imaging and offer a comprehensive and clear intraoperative view. AndDriven by Flexible Bronchoscope, can easily reach deep lesions. The controller is a remote control resembling a game console, capable of precise and flexible operation, and the flexible bronchoscope can achieve 360° angle adjustment.Currently, the initial version of the Monarch system has received FDA clearance and CE marking, but it is not the commercial version. On September 19, 2023, the commercial version, Maestro, received CE approval, and it is expected to receive FDA approval for the Maestro commercial version in the coming months. Johnson & Johnson's plan is,Limited release in the U.S. market in 2024, followed by broader commercialization efforts in 2025.VELYS Orthopedic Surgical Robot
VELYS Orthopedic Surgical Robot is the first product in its class to feature a portable design that can be placed next to the operating table, supporting plug-and-play functionality. It can be integrated into any operating room environment.Its system has excellent planning capabilities, optimizes doctors' surgical procedures, and adapts to their surgical habits.
VELYS™ can help surgeons accurately resect bone during total knee arthroplasty, aligning and positioning the implant relative to soft tissue without the need for preoperative imaging.Allow surgeons to perform procedures without using disposable instruments., significantly reducing the cost of surgery.
ItNot only the robotic system, but also the integrated intelligent platform and ATTUNE Total Knee System, VELYS™ can form a complete set of solutions. The system assists doctors in evaluating the bone anatomy and soft tissue capsule of the knee joint, helps plan the optimal prosthesis implantation position, and the gap balance data aids orthopedic surgeons in visualizing and predicting joint stability. The robotic system then assists doctors in executing the surgical plan.
NVIDIA Crosses Over into HealthcareThis is not the first time that NVIDIA has cooperated with medical device companies to jointly layout the healthcare market.Previously,Activ Surgical, Moon Surgical, and ProximieThree leading medical device startups have chosen the NVIDIA Clara Holoscan suite running on the IGX platform to power their surgical robotic systems.In addition,Medtronic has also chosen to collaborate with NVIDIA,Integrating its medical-grade Holoscan and IGX platforms into the GI Genius AI-assisted colonoscopy system to provide doctors with AI-enhanced diagnostic images.Medtronic
In March this year,Medtronic once announced that it would cooperate with chipmaker NVIDIA.By embedding its medical-grade real-time AI computing software platform, NVIDIA Holoscan, and industrial-grade edge AI hardware platform, NVIDIA IGX, into the GI Genius AI-assisted colonoscopy system, doctors are provided with AI-enhanced diagnostic images. Holoscan facilitates the introduction of new AI applications into clinical environments by offering full-stack infrastructure for scalable, software-defined streaming data processing at the edge.
With NVIDIA Holoscan and IGX platforms,Developers can efficiently train and validate AI models within the Cosmo Innovation Center, then host AI-powered applications on Medtronic's Software as a Medical Device (SaMD) app marketplace — the GI Genius AI Access platform.Making software-defined medical devices possible.
Activ Surgical
Activ Surgical Chooses NVIDIA Clara Holoscan to Accelerate Development of Its AI and Augmented Reality Solutions for Real-Time Surgical Guidance. The Boston-based company's ActivSight technology allows surgeons to view critical physiological structures and functions, such as blood flow, that are invisible to the naked eye.
Activ Surgical Aims to Revolutionize Surgical Treatment Through Augmented Reality, Artificial Intelligence, and Machine Learning TechnologiesAmong them, the company's surgical intelligence platform, ActiveEdge, can enhance surgeons' decision-making abilities during operations through big data analysis based on artificial intelligence, thereby reducing unexpected surgical errors. The ActivSight imaging module aims to seamlessly upgrade existing operating room equipment, acting as the "eyes" of the ActiveEdge platform, and allows surgeons to...AR TechnologyAccess critical visual data during the surgical procedure.
According to reports, several major hospital networks in the United States and Europe have piloted Activ Surgical's products, and the ActivSight imaging module is expected to be widely available in 2022.
Moon Surgical
Moon Surgical, a Paris-based robotic surgery company, is designing Maestro, an accessible adaptive surgical assistance robotic system that can work in conjunction with equipment and workflows already in place in the operating room.The company has been able to focus its engineering resources on AI algorithms and other unique functionalities, saving time and resources by adopting Clara Holoscan, which has helped them compress their development timeline.
MaestroIt is actually a collaborative operation robot platform (not similar to the Da Vinci surgical robot), providing surgeons with stable retraction, camera fixation, and two additional arms. The surgeon always controls the arms and can position them in any required manner, safely and reliably. The company is currently developing intraoperative camera tracking software that will enable the camera arm to automatically track the instrument manipulated by the surgeon. Additionally, embedded room sensing (equivalent to high-resolution "monitoring") cameras track the surgeon’s movements and the operating room environment to ultimately position the arms automatically in the optimal configuration before surgery begins.
Moon Surgical
Proximie
London-based Proximie is building a telepresence platform to enable real-time remote surgeon collaboration.Clara Holoscan will allow the company to provide local video processing in the operating room, enhancing user performance while maintaining data privacy and reducing cloud computing costs.
Proximie Founder and CEO Dr. Nadine Hach-Haram said, "We are thrilled to partner with NVIDIA to strengthen the health ecosystem and advance our mission of connecting operating rooms globally. Through this collaboration, we are able to deliver the most immersive experience possible and provide resilient digital solutions that enable operating room equipment worldwide to communicate with each other and gain valuable insights."
Proximie has been deployed in over 500 operating rooms worldwide and has recorded tens of thousands of surgical procedures to date.
--
By combining Johnson & Johnson's extensive experience in the medical technology field with NVIDIA's leading technology in artificial intelligence, we can expect to see more innovative healthcare solutions. The collaboration between these two giants will not only enhance the intelligence of medical devices and improve data analysis capabilities but also provide limitless possibilities for the digital transformation and future innovation of the entire healthcare industry.Instrument之家 will continue to follow up.
More exciting content
Welcome to follow WeChat Video Channel
BusinessBusiness cooperation email: qxzj@landianyiliao.com
